Scientists have utilised AI to predict T cell receptors, advancing personalised medicine, and boosting immunotherapy and vaccine development.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
The Sensory Science concept grew from the aim to “bring the beauty of the microscope to life for the low-vision and blind community”, and make science more accessible.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Fifteen years of patient data has revealed an important link between hospital-acquired infections and seizure and epilepsy onset.
A blood test that accurately detects the ongoing effects of sport-related concussion has the potential to help pinpoint when a player can safely return.
Clinical trials of an mRNA vaccine have begun, and researchers expect broadly positive outcomes in the fight against the widespread illness.
The finding arose from long-term follow-up of patients who received human growth hormone that was taken from brain tissue of deceased donors, but the risk is very low – and you can’t “catch” it like a virus.
A new trial is looking for chemical markers in the breath of people with silicosis. A second project will test drugs that may help lung scarring.
The groundbreaking identification of a specific T-cell receptor in healthy people without lupus has the potential to treat not only that disease, but approximately 100 autoimmune diseases known to have a similar pathology.
A recent study from Sweden found people with a history of chronic stress or depression had a heightened risk of developing Alzheimer’s disease.
Snake envenomation remains a significant health challenge in the ASEAN region, but the development of a universal antivenom holds great promise in mitigating its impact.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
The Victorian Heart Hospital, which opened in February, brings researchers to where the patients are, and already there’s a real buzz about the place.
On a new episode of Monash University’s “What Happens Next?” podcast, meet the healthcare providers and advocates working tirelessly to ensure that we don't lose ground in the global fight for reproductive rights.
As Alzheimer’s cases grow, scientists have been deep in debate over its causes. Now, with treatments are on the horizon, the new race is to ready the health system.
The country ranks fifth in the Western Pacific, with 4.4 million adults diagnosed with diabetes in 2021, but there’s a way forward to combat the disease.
It’s a long-term treatment – people having allergen immunotherapy typically notice improved symptoms after six to 12 months.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
It’s too hot for bare feet, but that doesn’t mean you can cook a fry-up on the path outside your house. A frying pan is a much better tool for the job, because it conducts heat far more efficiently.
There’s no one “thing” we can blame for causing dementia, and why it’s so hard to find that silver bullet to stop it – particularly at older ages.
The lack of investment in the development and deployment of decentralised diagnostic devices in Australia, most importantly a COVID-19 nucleic acid test, is a public policy failure.
Dummy text
